查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1790326

儿童糖尿病管理市场规模、份额和趋势分析报告：按产品、技术、最终用途、地区和细分市场预测，2025 年至 2033 年

Pediatric Diabetes Management Market Size, Share & Trends Analysis Report By Product (Insulin Pump, Insulin Pen), By Technology (Connected, Non-Connected), By End Use (Homecare, Pediatric Clinics), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

儿童糖尿病管理市场概况

2024 年全球儿童糖尿病管理市场规模估计为 55.9 亿美元，预计到 2033 年将达到 131.1 亿美元，2025 年至 2033 年的复合年增长率为 9.96%。该市场的成长是由全球儿童和青少年糖尿病（尤其是 1 型糖尿病）盛行率的上升所推动的，这大大增加了对有效监测和治疗解决方案的需求。

血糖监测 (BGM)、连续血糖监测 (CGM) 和胰岛素输送系统的技术进步提高了准确性、便利性和依从性，使其适合儿科使用。在全球范围内，1 型糖尿病仍然是儿童中最常见的糖尿病类型。然而，儿童肥胖、久坐不动的生活方式和不良饮食习惯的增加导致年轻时诊断出 2 型糖尿病的人数显着增加。根据国际糖尿病联盟的数据，到 2022 年，约有 152 万 20 岁年轻人将患有糖尿病。糖尿病的高盛行率推动了对持续监测和长期疾病管理的需求，从而促进了对以儿科为重点的糖尿病护理解决方案的需求。越来越多的监管支持和针对儿科病患小组的糖尿病治疗倡议将进一步推动市场成长。

糖尿病管理设备的技术进步正在显着影响市场成长，因为舒适性、易用性和即时洞察对于疾病依从性至关重要。越来越多的公司正在投资开发专为儿童和青少年设计的紧凑、微创且易于使用的设备。无管胰岛素帮浦、感测器寿命更长的连续血糖监测仪 (CGM) 以及智慧型手机连接系统等创新技术正在提高患者的依从性和家长监护能力。这些设备可自动注射胰岛素并产生预测警报，最大限度地降低低血糖和高血糖的风险，并减轻婴儿和看护者的负担。

此外，市场参与者正致力于引入儿科专用设计功能，例如产品微型化，进一步提升其普及率。例如，2023年7月，Tandem Diabetes Care的微型胰岛素帮浦Tandem Mobi获得了FDA批准，可用于儿科（6岁及以上）和成人。该帮浦可透过iPhone应用程式控制，并与CGM（动态血糖监测）相容。其尺寸仅为t:slim X2的一半，整合了Control IQ自动化系统，并具有更短的导管和远端更新功能。

目录

第一章调查方法与范围

第二章执行摘要

3. 儿童糖尿病管理市场变数、趋势与范围

  • 市场体系展望
    • 补贴市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 儿童糖尿病管理市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析

4. 儿童糖尿病管理市场：产品、预测与趋势分析

  • 细分仪表板
  • 儿童糖尿病管理市场：2024 年和 2033 年产品变化分析和市场占有率
  • 血糖值监测仪（BGM）
  • 连续血糖监测仪（CGM）
  • 胰岛素帮浦
  • 胰岛素笔
  • 胰岛素注射器

5. 儿童糖尿病管理市场（按技术、估计和趋势分析）

  • 细分仪表板
  • 儿童糖尿病管理市场：2024 年和 2033 年技术变革分析和市场占有率
  • 连接装置
  • 未连接的设备

6. 儿童糖尿病管理市场：最终用途、估计和趋势分析

  • 细分仪表板
  • 儿童糖尿病管理市场：2024 年和 2033 年最终用途变化分析和市场占有率
  • 医院
    • 综合医院
    • 儿童医院
  • 居家医疗
  • 小儿科诊所

7. 儿童糖尿病管理市场：依产品、技术和最终用途区域的估计和趋势分析

  • 区域展望
  • 儿童糖尿病管理市场：2024 年和 2033 年区域差异分析和市场占有率
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 市场参与企业分类
  • 主要企业简介
    • Medtronic
    • Dexcom
    • Abbott
    • Tandem Diabetes Care
    • Insulet Corporation
    • Novo Nordisk
    • Sanofi
    • Eli Lilly and Company
    • Roche Diabetes Care
    • Ascensia Diabetes Care
Product Code: GVR-4-68040-651-8

Pediatric Diabetes Market Summary

The global pediatric diabetes management market size was estimated at USD 5.59 billion in 2024 and is projected to reach USD 13.11 billion by 2033, growing at a CAGR of 9.96% from 2025 to 2033. The growth of the market is attributed to the rising global prevalence of diabetes, particularly Type 1, among children and adolescents, which has significantly increased the demand for effective monitoring and treatment solutions.

Technological advancements in blood glucose monitoring (BGM), continuous glucose monitoring (CGM), and insulin delivery systems have improved accuracy, convenience, and compliance, making them more suitable for pediatric use. Globally, type 1 diabetes remains the most common form in children, but the rising incidence of childhood obesity, sedentary lifestyles, and poor dietary habits has led to a significant rise in type 2 diabetes diagnoses in younger age groups. According to the International Diabetes Federation, around 1.52 million people aged 20 years had diabetes in 2022. This high prevalence of diabetes is increasing demand for constant monitoring and long-term disease management, thereby contributing to demand for pediatric-focused diabetes care solutions. The increasing regulatory support and initiatives to address diabetes in pediatric patient groups further fuel the market growth.

Technological advancements in diabetes management devices have significantly influenced the market growth as comfort, usability, and real-time insights are crucial for disease adherence. Companies are increasingly investing in the development of compact, minimally invasive, and user-friendly devices that cater specifically to children and adolescents. Innovations such as tubeless insulin pumps, continuous glucose monitors (CGMs) with extended sensor life, and smartphone-connected systems have improved patient compliance and parental monitoring. These devices reduce the burden on both children and caregivers by automating insulin dosing and generating predictive alerts, minimizing the risks of hypoglycemia or hyperglycemia.

Additionally, market players are focusing on launching pediatric-specific design features, such as miniaturization of products, further contributing to their increasing adoption. For instance, in July 2023, Tandem Diabetes Care's miniature-sized insulin pump, Tandem Mobi, controllable via iPhone app and compatible with CGM, got FDA clearance for children (>=6 years) and adults. Half the size of t : slim X2, it integrates Control IQ automation, features shorter tubing, and remote updates.

Global Pediatric Diabetes Management Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pediatric diabetes management market report on the basis of product, technology, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Blood Glucose Monitors (BGM)
  • Continuous Glucose Monitors (CGM)
  • Insulin Pumps
  • Insulin Pens
  • Insulin Syringes
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Connected Devices
  • Non-connected Devices
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
    • General Hospitals
    • Children Hospitals
  • Homecare
  • Pediatric Clinics
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Kuwait
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Purchased database.
  • 1.5. GVR's internal database
  • 1.6. Secondary sources
  • 1.7. Third Party Perspective
  • 1.8. Primary research
  • 1.9. Details of primary research
  • 1.10. Information or Data Analysis
  • 1.11. Data analysis models
  • 1.12. Market Formulation & Validation
  • 1.13. Model Details
  • 1.14. Commodity flow analysis (Model 1)
  • 1.15. Approach 1: Commodity flow approach
  • 1.16. Volume price analysis (Model 2)
  • 1.17. Approach 2: Volume price analysis
  • 1.18. List of Secondary Sources
  • 1.19. List of Primary Sources
  • 1.20. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Pediatric Diabetes Management Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising incidence of diabetes in children and adolescents
      • 3.2.1.2. Technological advancements in diabetes management devices
      • 3.2.1.3. Increasing awareness and early diagnosis
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of certain diabetes management devices
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Rising preference toward advanced diabetes management devices
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Caregiver burden and patient education challenges
  • 3.3. Pediatric Diabetes Management Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Pediatric Diabetes Management Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Pediatric Diabetes Management Market: Product Movement Analysis & Market Share, 2024 & 2033
  • 4.3. Blood Glucose Monitors (BGM)
    • 4.3.1. Blood Glucose Monitors (BGM) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Continuous Glucose Monitors (CGM)
    • 4.4.1. Continuous Glucose Monitors (CGM) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Insulin Pumps
    • 4.5.1. Insulin Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Insulin Pens
    • 4.6.1. Insulin Pens Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Insulin Syringes
    • 4.7.1. Insulin Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Pediatric Diabetes Management Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Pediatric Diabetes Management Market: Technology Movement Analysis & Market Share, 2024 & 2033
  • 5.3. Connected Devices
    • 5.3.1. Connected Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Non-connected Devices
    • 5.4.1. Non-connected Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Pediatric Diabetes Management Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Pediatric Diabetes Management Market: End-use Movement Analysis & Market Share, 2024 & 2033
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. General Hospitals
      • 6.3.2.1. General Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Children Hospitals
      • 6.3.3.1. Children Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Homecare
    • 6.4.1. Homecare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Pediatric Clinics
    • 6.5.1. Pediatric Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Pediatric Diabetes Management Market: Regional Estimates & Trend Analysis by Product, Technology, End-Use

  • 7.1. Regional Outlook
  • 7.2. Pediatric Diabetes Management Market: Regional Movement Analysis & Market Share, 2024 & 2033
  • 7.3. North America
    • 7.3.1. North America Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Scenario
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. U.S. Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Scenario
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Canada Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Scenario
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Mexico Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. UK Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Germany Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. France Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Scenario
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Italy Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Scenario
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Spain Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Scenario
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Denmark Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Scenario
      • 7.4.8.4. Reimbursement Scenario
      • 7.4.8.5. Sweden Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Scenario
      • 7.4.9.4. Reimbursement Scenario
      • 7.4.9.5. Norway Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Japan Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. China Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Reimbursement Scenario
      • 7.5.4.5. India Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Reimbursement Scenario
      • 7.5.5.5. South Korea Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Reimbursement Scenario
      • 7.5.6.5. Australia Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Reimbursement Scenario
      • 7.5.7.5. Thailand Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Brazil Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Argentina Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. Middle East & Africa Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Reimbursement Scenario
      • 7.7.2.5. South Africa Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Reimbursement Scenario
      • 7.7.3.5. Saudi Arabia Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Scenario
      • 7.7.4.4. Reimbursement Scenario
      • 7.7.4.5. UAE Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Scenario
      • 7.7.5.4. Reimbursement Scenario
      • 7.7.5.5. Kuwait Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Medtronic
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Dexcom
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Abbott
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Tandem Diabetes Care
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Insulet Corporation
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Novo Nordisk
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Sanofi
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Eli Lilly and Company
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Roche Diabetes Care
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Ascensia Diabetes Care
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product Benchmarking
      • 8.2.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global pediatric diabetes management market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 4 Global pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 5 Global pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 6 North America pediatric diabetes management market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 8 North America pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 9 North America pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 10 U.S. pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 11 U.S. pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 12 U.S. pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 13 Canada pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 14 Canada pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 15 Canada pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 16 Mexico pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 17 Mexico pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 18 Mexico pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 19 Europe pediatric diabetes management market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 21 Europe pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 22 Europe pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 23 UK pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 24 UK pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 25 UK pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 26 Germany pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 27 Germany pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 28 Germany pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 29 France pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 30 France pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 31 France pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 32 Italy pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 33 Italy pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 34 Italy pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 35 Spain pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 36 Spain pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 37 Spain pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 38 Denmark pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 39 Denmark pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 40 Denmark pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 41 Sweden pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 42 Sweden pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 43 Sweden pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 44 Norway pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 45 Norway pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 46 Norway pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific pediatric diabetes management market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 51 China pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 52 China pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 53 China pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 54 Japan pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 55 Japan pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 56 Japan pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 57 India pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 58 India pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 59 India pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 60 South Korea pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 61 South Korea pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 62 South Korea pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 63 Australia pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 64 Australia pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 65 Australia pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 66 Thailand pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 67 Thailand pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 68 Thailand pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 69 Latin America pediatric diabetes management market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 71 Latin America pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 72 Latin America pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 73 Brazil pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 74 Brazil pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 75 Brazil pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 76 Argentina pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 77 Argentina pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 78 Argentina pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 79 MEA pediatric diabetes management market, by country, 2021 - 2033 (USD Million)
  • Table 80 MEA pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 81 MEA pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 82 MEA pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 83 South Africa pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 84 South Africa pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 85 South Africa pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 89 UAE pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 90 UAE pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 91 UAE pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 94 Kuwait pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Pediatric diabetes management market segmentation
  • Fig. 3 Market research process
  • Fig. 4 Information procurement process
  • Fig. 5 Primary research pattern
  • Fig. 6 Pediatric diabetes management market snapshot, 2024 (USD Million)
  • Fig. 7 Segment snapshot, USD Million
  • Fig. 8 Competitive landscape snapshot
  • Fig. 9 Penetration & growth prospect mapping
  • Fig. 10 Market driver analysis (Current & future impact)
  • Fig. 11 Market restraint analysis (Current & future impact)
  • Fig. 12 Primary market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Blood glucose monitors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Continuous glucose monitors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Insulin pumps market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Insulin pens market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Insulin syringes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Connected devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Non-connected devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 General hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Children hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Homecare market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Pediatric clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Pediatric diabetes management market: Regional key takeaways (USD Million)
  • Fig. 26 Pediatric diabetes management market: Regional outlook, 2023 & 2033 (USD Million)
  • Fig. 27 North America pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Canada pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Mexico pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Europe pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 UK pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Germany pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 France pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Spain pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Italy pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Sweden pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Norway pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Denmark pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Asia Pacific pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 China pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Japan pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 India pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 South Korea pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Australia pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Thailand pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Latin America pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Brazil pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Argentina pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Middle East and Africa pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 South Africa pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Saudi Arabia pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 UAE pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Kuwait pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 List of key emerging companies
  • Fig. 56 Company market share analysis, 2024
  • Fig. 57 Market differentiators
  • Fig. 58 Competitive dashboard analysis
  • Fig. 59 Regional network map